Kenvue Inc. (NYSE:KVUE) Declares $0.21 Quarterly Dividend

Key Points

• Kenvue declared a quarterly dividend of $0.2075 per share payable May 27 to shareholders of record May 13, which represents about a 4.8% annualized yield.
• The dividend appears sustainably covered by earnings — a current payout ratio of 68% and analysts' forecast of roughly $1.16 EPS next year imply an expected payout ratio near 71.6%, supporting the company's $0.83 annual dividend.
• Shares traded at $17.21 (market cap ~$33.0B) and Kenvue carries a consensus analyst rating of Hold with an average target price of $19.33.

Kenvue Inc. (NYSE:KVUE - Get Free Report) declared a quarterly dividend on Wednesday, April 29th. Shareholders of record on Wednesday, May 13th will be paid a dividend of 0.2075 per share on Wednesday, May 27th. This represents a c) dividend on an annualized basis and a yield of 4.8%. The ex-dividend date is Wednesday, May 13th.

Kenvue has a dividend payout ratio of 68.0% meaning its dividend is sufficiently covered by earnings. Research analysts expect Kenvue to earn $1.16 per share next year, which means the company should continue to be able to cover its $0.83 annual dividend with an expected future payout ratio of 71.6%.

Kenvue Stock Performance

NYSE:KVUE traded down $0.34 during trading hours on Wednesday, reaching $17.21. The company had a trading volume of 13,245,781 shares, compared to its average volume of 35,508,793. Kenvue has a 1-year low of $14.02 and a 1-year high of $25.17. The firm has a market cap of $33.03 billion, a PE ratio of 22.34, a price-to-earnings-growth ratio of 3.98 and a beta of 0.61. The business's 50 day moving average price is $17.78 and its 200-day moving average price is $17.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The company had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. During the same period in the previous year, the company posted $0.26 earnings per share. Kenvue's revenue for the quarter was up 3.2% on a year-over-year basis. Research analysts forecast that Kenvue will post 1.1 EPS for the current year.

Analyst Ratings Changes

KVUE has been the subject of a number of analyst reports. Canaccord Genuity Group boosted their price target on Kenvue from $17.00 to $18.00 and gave the company a "hold" rating in a report on Wednesday, February 18th. Jefferies Financial Group downgraded Kenvue from a "buy" rating to a "hold" rating and decreased their price target for the company from $23.00 to $18.00 in a report on Friday, January 30th. Citigroup decreased their price target on Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a report on Wednesday, April 15th. Barclays decreased their price target on Kenvue from $19.00 to $18.00 and set an "equal weight" rating for the company in a report on Tuesday, April 14th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Kenvue in a research note on Wednesday, April 8th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. According to data from MarketBeat.com, Kenvue currently has an average rating of "Hold" and a consensus target price of $19.33.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.